Physician profile
Jay M Barbakoff
NPI 1003994260
$2,307.88
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,486 · 2020: $802 · 2021: $19.52.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $530.26 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $302.96 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $269.13 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $186.95 | 2019-2020 | |
| Genentech USA, INC. | $136.40 | 2019 | |
| Novartis Pharmaceuticals Corporation | $130.58 | 2019-2020 | |
| Mylan Specialty L.P. | $97.78 | 2019-2020 | |
| Electromed, INC. | $80.25 | 2019 | |
| Genzyme Corporation | $76.27 | 2019 | |
| Merck Sharp & Dohme LLC | $70.97 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $70.71 | 2019-2020 | |
| Advanced Respiratory, INC | $66.92 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $62.35 | 2019-2020 | |
| Philips North America LLC | $37.94 | 2019-2020 | |
| Pfizer INC. | $37.05 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $32.44 | 2020 | |
| La Jolla Pharmaceutical Company | $30.41 | 2020 | |
| Tetraphase Pharmaceuticals, INC. | $20.42 | 2019 | |
| Apria Healthcare LLC | $19.52 | 2021 | |
| Chiesi USA, INC. | $19.00 | 2019 | |
| Olympus America INC. | $15.08 | 2020 | |
| Janssen Pharmaceuticals, INC | $14.49 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Barbakoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.